stockrow
Friday 6 November 2026
Export DYN’s income statement to Excel — free account
Dyne Therapeutics, Inc.
- EPS
- −11.3%
- Free cash flow
- −39.1%
- Total debt
- +116.0%
Quarter to June 2026, against a year earlier
18.21
0.85
+4.90%
Follow DYN
Alert me
Dyne Therapeutics, Inc. (DYN) Current ratio
Dyne Therapeutics, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 12.0×, down 10.2× from fiscal 2025 (22.3×). Over the past ten years it has ranged from 2.5× (fiscal 2023) to 31.8× (fiscal 2020); the current reading is higher than 88% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 22.3× | 42.64% |
| FY2024 | 15.6× | 516.17% |
| FY2023 | 2.5× | (73.22%) |
| FY2022 | 9.5× | (28.97%) |
| FY2021 | 13.3× | (58.18%) |
| FY2020 | 31.8× | 408.55% |
| FY2019 | 6.3× | (45.45%) |
| FY2018 | 11.5× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 12.0× | (39.67%) |
| Mar 2026 | 19.9× | (10.47%) |
| Dec 2025 | 22.3× | 65.19% |
| Sep 2025 | 13.5× | (19.95%) |
| 21 more quarters | Free account |
Against its own ten years
Low 2.5×
High 31.8×
Ten-year median
12.4×
Current reading's percentile
88
Current ratio against peers
| Company | Current ratio |
|---|---|
| ELVN Enliven Therapeutics, Inc. compare | 64.1× |
| VRDN Viridian Therapeutics, Inc. compare | 14.5× |
| DYN Dyne Therapeutics, Inc. | 12.0× |
| CELC Celcuity, Inc. compare | 8.9× |
| VKTX Viking Therapeutics, Inc. compare | 7.3× |
| DNLI Denali Therapeutics Inc. compare | 6.2× |
| ACAD ACADIA Pharmaceuticals Inc. compare | 3.8× |
| TLX Telix Pharmaceuticals Limited compare | 2.0× |
| TARS Tarsus Pharmaceuticals, Inc. compare | 2.0× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)